Cargando…

Tumour volume distribution can yield information on tumour growth and tumour control

BACKGROUND: It is shown that tumour volume distributions can yield information on two aspects of cancer research: tumour induction and tumour control. MATERIALS AND METHODS: From the hypothesis that the intrinsic distribution of breast cancer volumes follows an exponential distribution, firstly the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Uwe, Besserer, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948830/
https://www.ncbi.nlm.nih.gov/pubmed/34119384
http://dx.doi.org/10.1016/j.zemedi.2021.04.002
Descripción
Sumario:BACKGROUND: It is shown that tumour volume distributions can yield information on two aspects of cancer research: tumour induction and tumour control. MATERIALS AND METHODS: From the hypothesis that the intrinsic distribution of breast cancer volumes follows an exponential distribution, firstly the probability density function of tumour growth time was deduced via a mathematical transformation of the probability density functions of tumour volumes. In a second step, the distribution of tumour volumes was used to model the variation of the clonogenic cell number between patients in order to determine tumour control probabilities for radiotherapy patients. RESULTS: Distribution of lag times, i.e. the time from the appearance of the first fully malignant cell until a clinically observable cancer, can be used to deduce the probability of tumour induction as a function of patient age. The integration of the volume variation with a Poisson-TCP model results in a logistic function which explains population-averaged survival data of radiotherapy patients. CONCLUSIONS: The inclusion of tumour volume distributions into the TCP formalism enables a direct link to be deduced between a cohort TCP model (logistic) and a TCP model for individual patients (Poisson). The TCP model can be applied to non-uniform tumour dose distributions.